{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "Amount",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "pubchem:586",
      "entity_text" : "creatine",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false,
    "context" : {
      "Species" : [ "taxonomy:10090" ],
      "TissueType" : [ "tissuelist:TS-0923" ],
      "Organ" : [ "uberon:UBERON:0000479" ]
    }
  },
  "verbose_text" : "Using a treatment regimen that targeted a plasma concentration of 5-10 mug/ml, treatment with PTC124 was able to improve multiple phenotypes, including a functional strength deficit, protection against contraction induced injury, and a reduction in serum creatine kinase levels.",
  "reading_complete" : "2020-08-02T14:26:39Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-02T14:25:13Z",
  "trigger" : "levels",
  "evidence" : [ "creatine kinase levels" ],
  "pmc_id" : "4094583",
  "score" : 0
}